Overview

A Study in Healthy Men to Test Whether Itraconazole Influences the Amount of BI 1584862 in the Blood

Status:
Completed
Trial end date:
2023-11-10
Target enrollment:
Participant gender:
Summary
The main objective of this trial is to investigate the effect on the exposure of BI 1584862 in plasma when given as single dose together with multiple doses of itraconazole (Test, T) as compared to BI 1584862 when given alone as oral single dose (Reference, R).
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Itraconazole